Mayo Clinic: Breast Neoplasms trials

The registry lists 134 Breast Neoplasms studies with Mayo Clinic as lead sponsor. 23 are open to participants now and 22 have results posted.

Early Phase 1 10Phase 1 17Phase 2 24Phase 3 2No phase 83(a study in two phases counts in both)

Studies

Page 1 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasRecruitingNCT07285044Phase 2
• Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer RiskRecruitingNCT07207564
• A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without ReconstructionRecruitingNCT07047872Not applicable
• Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing RadiotherapyRecruitingNCT06953245
• Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung CancerRecruitingNCT06855524Phase 2
• A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer SurvivorsRecruitingNCT06831838Not applicable
• Postoperative Outcomes and Patient Satisfaction With Mayo Clinic Florida Care Hotel After Mastectomy and Tissue Expander PlacementRecruitingNCT06783179
• Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast CancerRecruitingNCT06635980Phase 2
• Adaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast CancerRecruitingNCT06525766Phase 2
• DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer PatientsRecruitingNCT06388122
• Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast CancerRecruitingNCT06217874
• Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast AbnormalitiesRecruitingNCT06058650Not applicable
• Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung CancerRecruitingNCT05746325Not applicable
• 3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast CancerRecruitingNCT05704283Early Phase 1
• Low Dose Aspirin for the Prevention of Postpartum Related Breast CancerRecruitingNCT05557877Phase 2
• TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast CancerRecruitingNCT05507879
• Breast Cancer, Reasoning, and Activity InterventionRecruitingNCT04816006Not applicable
• Quantitative Microvasculature Imaging for Breast Cancer Detection and MonitoringRecruitingNCT04799535
• Development of Patient Derived Xenografts (PDX) in Patients With Breast CancerRecruitingNCT04703244
• 3D Ultrasound Breast ImagingRecruitingNCT04692818Not applicable
• A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast CancerRecruitingNCT04521764Phase 1
• Cancer Genetic Testing in Ethnic PopulationsRecruitingNCT04475640Not applicable
• Intravital Microscopy in Human Solid TumorsRecruitingNCT03823144Not applicable
• Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast CancerCompletedNCT07216274Not applicableResults posted
• Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer RiskTerminatedNCT04570956Phase 2Results posted
• Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast CancerCompletedNCT04294225Phase 2Results posted
• Cryotherapy for the Prevention of Taxane-Induced Sensory Neuropathy of the Hands and Feet in Breast Cancer PatientsCompletedNCT04256512Not applicableResults posted
• Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast CancerActive, not recruitingNCT03941730Phase 2Results posted
• Evaluation of Magseed as Localization Device for Biopsy Proven Metastatic Axillary Lymph NodesTerminatedNCT03718455Not applicableResults posted
• Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After SurgeryCompletedNCT03324802Phase 3Results posted
• Molecular Breast Imaging and Digital Breast Tomosynthesis in Screening Patients With Dense Breast TissueCompletedNCT03220893Not applicableResults posted
• Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast CancerCompletedNCT03106415Phase 1/2Results posted
• Behavioral and Psychological Impact of Returning Breast Density Results to LatinasCompletedNCT02910986Not applicableResults posted
• Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast CancerCompletedNCT02860000Phase 2Results posted
• A Trial of 15 Fraction vs 25 Fraction Pencil Beam Scanning Proton Radiotherapy After Mastectomy in Patients Requiring Regional Nodal IrradiationCompletedNCT02783690Phase 2Results posted
• A Study of Accelerated 3 Fraction Photon,Proton or Brachytherapy for Early Invasive and Noninvasive Breast CaCompletedNCT02453737Phase 2Results posted
• Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense BreastsCompletedNCT01925170Not applicableResults posted
• Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast CancerTerminatedNCT00998738Phase 3Results posted
• Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast CancerTerminatedNCT00873366Results posted
• Molecular Breast Imaging as a Screening Tool for Women With Dense BreastsCompletedNCT00620373Not applicableResults posted
• Comparison of MRI and Molecular Breast Imaging in Breast Diagnostic EvaluationCompletedNCT00591864Not applicableResults posted
• Sorafenib and Letrozole, Anastrozole, or Exemestane in Treating Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Metastatic Breast CancerTerminatedNCT00573755Phase 2Results posted
• Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast CancerCompletedNCT00436917Not applicableResults posted
• Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By SurgeryCompletedNCT00436566Phase 2Results posted
• ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast CancerCompletedNCT00110084Phase 2Results posted
• WE-CARE Community Health Forums to Increase Breast Cancer Screening and Clinical Trial Participation for Rural and Low Income WomenTerminatedNCT07644702Not applicable
• Virtual Support Platform (HERCaRE Application) for the Improvement of Survivorship Among Black Breast Cancer SurvivorsCompletedNCT07126522Not applicable
• ZTE MRI Pulse Sequence Use for Visualization of Bone Cement, Breast Biopsy MarkersCompletedNCT06873802
• Defining Musical Toxicity and Its Effect on Patient Well-beingWithdrawnNCT06494046
• A Correlational Study: Breast Cancer-related Chest Wall Lymphedema, Quality of Life, and Shoulder FunctionCompletedNCT06285747
• MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer SurvivorsTerminatedNCT06274034Early Phase 1
• Exploring Cultural Acceptability of Community Breast Cancer Risk Assessment Among Hispanic Women in Maricopa CountyCompletedNCT06112795
• Genetic Testing to Improve Management of Patients Undergoing Breast BiopsySuspendedNCT06060561
• Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic TherapyActive, not recruitingNCT06055881Not applicable
• CARE: Cancer Risk Perception and Women of ColorCompletedNCT06036875
• A Study of Effect of Megakaryocytes and Platelets in Breast CancerCompletedNCT06011824
• A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer PatientsActive, not recruitingNCT05889988
• Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic WomenTerminatedNCT05755269
• Long Term Followup of Patients Enrolled in MC1137, BEAUTY StudyActive, not recruitingNCT05703399
• Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer PatientsActive, not recruitingNCT05612100
• Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast CancerTerminatedNCT05447910
• Tonation Breathing Technique Method to Ease Aromatase Inhibitor-induced Joint and/or Muscle PainCompletedNCT05412953Not applicable
• Evaluating Patient Reported Outcomes in Radiation Therapy, the PRO-RT StudyCompletedNCT05224271
• 3D Ultrasound Microvessel Imaging for Breast MassesCompletedNCT04925817Early Phase 1
• Optimizing Treatment of Stage IV Breast Cancer Through Real-Time Disease MonitoringSuspendedNCT04906369
• Nonlinear Elasticity Mapping of Breast MassesCompletedNCT04863443
• Effects of Probiotics on the Gut Microbiome and Immune System in Operable Stage I-III Breast or Lung CancerCompletedNCT04857697Early Phase 1
• Classification of Breast Masses Based on Visco-elastic Properties Using SAVE MethodCompletedNCT04841252
• Determining Molecular Drivers of Radiation DermatitisCompletedNCT04764682
• Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast CancerCompletedNCT04693338Phase 1
• Mayo Designed Soft Tissue Ultrasound-Detectable MarkerCompletedNCT04674852Not applicable
• Platelet Rich Plasma for the Treatment of Genitourinary Syndrome of Menopause in Patients With Stage 0-III Breast CancerCompletedNCT04535323Phase 1
• Genetic Risk Estimations for Influencing Decision Making in Women at High Risk of Breast Cancer, GENRE 2 StudyActive, not recruitingNCT04474834
• Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit StudyCompletedNCT04456140Phase 1
• Circulating Tumor DNA and Immunophenotyping as Potential Biomarkers With Regional Nodal Irradiation for Breast CancerActive, not recruitingNCT04308720
• Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast CancerWithdrawnNCT04249167Early Phase 1
• Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR TrialWithdrawnNCT04190433Phase 2
• RBX7455 Before Surgery for the Treatment of Operable Breast CancerTerminatedNCT04139993Phase 1
• Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV CancerCompletedNCT04067960Early Phase 1
• Comprehensive Genetic Assessment, Risk and Education in a Mammography PilotCompletedNCT04002986Not applicable
• Adipose-Induced Regeneration of Breast Skin to Treat Post-Mastectomy Radiation Injury in Breast Cancer PatientsWithdrawnNCT03981718Not applicable
• Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast CancerCompletedNCT03941743Phase 1
• Treating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart FailureTerminatedNCT03879629Phase 2
• Team Based Psychosocial Care to Promote, Maintain and Restore Wellness of Breast Cancer PatientsCompletedNCT03770598Not applicable
• Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast CancerActive, not recruitingNCT03737695
• Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal AtrophyWithdrawnNCT03666819Phase 2
• Evaluating Mepitel in Post-mastectomy Patients and the Role of the Skin Microbiome in Radiation DermatitisCompletedNCT03519438
• Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast CancerTerminatedNCT03432741Phase 1
• Preventing Lymphedema in Axillary Lymph Node DissectionTerminatedNCT03428581Not applicable
• Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer SurvivorsCompletedNCT03407716Early Phase 1
• Engineering Gut Microbiome to Target Breast CancerCompletedNCT03358511Not applicable
• Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine TherapyActive, not recruitingNCT03281902
• Estrogen Receptor Expression in Breast Cancer - Assessed With Positron Emission MammographyWithdrawnNCT03266562Not applicable
• Pembrolizumab and Ruxolitinib Phosphate in Treating Patients With Metastatic Stage IV Triple Negative Breast CancerCompletedNCT03012230Phase 1
• Exercise Preconditioning and Breast Cancer CardiotoxicityCompletedNCT02842658Not applicable
• Comparison of Positron Emission Mammography and Contrast-enhanced Breast MRICompletedNCT02770586Not applicable
• TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid TumorsTerminatedNCT02650635Phase 1
• Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR MutationsCompletedNCT02646319Early Phase 1
• Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication UptakeCompletedNCT02517593Phase 1/2
• Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by SurgeryCompletedNCT02219789Phase 1